OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Novel Therapeutic Approaches in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Era of Targeted Therapy
Nathaniel R. Wilson, Marina Konopleva, Joseph D. Khoury, et al.
Clinical Lymphoma Myeloma & Leukemia (2021) Vol. 21, Iss. 11, pp. 734-740
Closed Access | Times Cited: 29
Nathaniel R. Wilson, Marina Konopleva, Joseph D. Khoury, et al.
Clinical Lymphoma Myeloma & Leukemia (2021) Vol. 21, Iss. 11, pp. 734-740
Closed Access | Times Cited: 29
Showing 1-25 of 29 citing articles:
Blastic plasmacytoid dendritic cell neoplasm: a comprehensive review in pediatrics, adolescents, and young adults (AYA) and an update of novel therapies
Branko Cuglievan, Jeremy Connors, Jiasen He, et al.
Leukemia (2023) Vol. 37, Iss. 9, pp. 1767-1778
Open Access | Times Cited: 23
Branko Cuglievan, Jeremy Connors, Jiasen He, et al.
Leukemia (2023) Vol. 37, Iss. 9, pp. 1767-1778
Open Access | Times Cited: 23
North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need
Naveen Pemmaraju, Hagop M. Kantarjian, Kendra Sweet, et al.
Blood (2022) Vol. 141, Iss. 6, pp. 567-578
Open Access | Times Cited: 30
Naveen Pemmaraju, Hagop M. Kantarjian, Kendra Sweet, et al.
Blood (2022) Vol. 141, Iss. 6, pp. 567-578
Open Access | Times Cited: 30
Unmet Clinical Needs and Management Recommendations for Blastic Plasmacytoid Dendritic Cell Neoplasm: A Consensus-based Position Paper From an Ad Hoc International Expert Panel
Livio Pagano, Pier Luigi Zinzani, Stefano Pileri, et al.
HemaSphere (2023) Vol. 7, Iss. 3, pp. e841-e841
Open Access | Times Cited: 13
Livio Pagano, Pier Luigi Zinzani, Stefano Pileri, et al.
HemaSphere (2023) Vol. 7, Iss. 3, pp. e841-e841
Open Access | Times Cited: 13
Blastic Plasmacytoid Dendritic Cell Neoplasm: A Comprehensive Review of the Disease, Central Nervous System Presentations, and Treatment Strategies
Shefali Mehra, Justin Taylor
Cells (2024) Vol. 13, Iss. 3, pp. 243-243
Open Access | Times Cited: 5
Shefali Mehra, Justin Taylor
Cells (2024) Vol. 13, Iss. 3, pp. 243-243
Open Access | Times Cited: 5
Integrated Clinical Genotype-Phenotype Characteristics of Blastic Plasmacytoid Dendritic Cell Neoplasm
C. Cameron Yin, Naveen Pemmaraju, M. James You, et al.
Cancers (2021) Vol. 13, Iss. 23, pp. 5888-5888
Open Access | Times Cited: 29
C. Cameron Yin, Naveen Pemmaraju, M. James You, et al.
Cancers (2021) Vol. 13, Iss. 23, pp. 5888-5888
Open Access | Times Cited: 29
Flow Cytometry Profiling of Plasmacytoid Dendritic Cell Neoplasms
Siba El Hussein, Wei Wang
Cancers (2024) Vol. 16, Iss. 11, pp. 2118-2118
Open Access | Times Cited: 4
Siba El Hussein, Wei Wang
Cancers (2024) Vol. 16, Iss. 11, pp. 2118-2118
Open Access | Times Cited: 4
Optimization of Adcitmer, a Monomethyl-Auristatin E bearing antibody-drug conjugate for the treatment of CD56-expressing cancers
Aurélie Drouin, Laurine Durand, C. Esnault, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 3, pp. e010897-e010897
Open Access
Aurélie Drouin, Laurine Durand, C. Esnault, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 3, pp. e010897-e010897
Open Access
Petechiae and a Persistent Violaceous Nodule: A Presentation of Blastic Plasmacytoid Dendritic Cell Neoplasm to Dermatology
Madison Anzelc, Christina Druskovich, Austin Cusick, et al.
Case Reports in Dermatological Medicine (2025) Vol. 2025, Iss. 1
Open Access
Madison Anzelc, Christina Druskovich, Austin Cusick, et al.
Case Reports in Dermatological Medicine (2025) Vol. 2025, Iss. 1
Open Access
Venetoclax and hypomethylating agents in older/unfit patients with blastic plasmacytoid dendritic cell neoplasm
Naseema Gangat, Marina Konopleva, Mrinal M. Patnaik, et al.
American Journal of Hematology (2021) Vol. 97, Iss. 2
Open Access | Times Cited: 25
Naseema Gangat, Marina Konopleva, Mrinal M. Patnaik, et al.
American Journal of Hematology (2021) Vol. 97, Iss. 2
Open Access | Times Cited: 25
Diagnostic management of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in close interaction with therapeutic considerations
Evgenii Shumilov, Paolo Mazzeo, Susanne Ghandili, et al.
Annals of Hematology (2024) Vol. 103, Iss. 5, pp. 1587-1599
Open Access | Times Cited: 3
Evgenii Shumilov, Paolo Mazzeo, Susanne Ghandili, et al.
Annals of Hematology (2024) Vol. 103, Iss. 5, pp. 1587-1599
Open Access | Times Cited: 3
Tagraxofusp as first-line treatment for blastic plasmacytoid dendritic cell neoplasm
Rocío Díaz Acedo, María Ángeles Domínguez Muñoz, Clara Navajas Laguna, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2022) Vol. 63, Iss. 7, pp. 1762-1764
Closed Access | Times Cited: 10
Rocío Díaz Acedo, María Ángeles Domínguez Muñoz, Clara Navajas Laguna, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2022) Vol. 63, Iss. 7, pp. 1762-1764
Closed Access | Times Cited: 10
CD123 and More: How to Target the Cell Surface of Blastic Plasmacytoid Dendritic Cell Neoplasm
Elodie Bôle‐Richard, Naveen Pemmaraju, Blandine Caël, et al.
Cancers (2022) Vol. 14, Iss. 9, pp. 2287-2287
Open Access | Times Cited: 9
Elodie Bôle‐Richard, Naveen Pemmaraju, Blandine Caël, et al.
Cancers (2022) Vol. 14, Iss. 9, pp. 2287-2287
Open Access | Times Cited: 9
Incidence, prognostic factors, and survival outcomes in patients with blastic plasmacytoid dendritic cell neoplasm: A retrospective study in the Surveillance, Epidemiology, and End Results database
Xiao-Jing Lin, Li Wang, Qian Hu, et al.
European Journal Of Haematology (2023) Vol. 110, Iss. 6, pp. 743-753
Closed Access | Times Cited: 5
Xiao-Jing Lin, Li Wang, Qian Hu, et al.
European Journal Of Haematology (2023) Vol. 110, Iss. 6, pp. 743-753
Closed Access | Times Cited: 5
Improved identification of clinically relevant Acute Leukemia subtypes using standardized EuroFlow panels versus non‐standardized approach
Rafik Terra, Vincent Éthier, Lambert Busque, et al.
Cytometry Part B Clinical Cytometry (2024)
Open Access | Times Cited: 1
Rafik Terra, Vincent Éthier, Lambert Busque, et al.
Cytometry Part B Clinical Cytometry (2024)
Open Access | Times Cited: 1
Blastic Plasmocytoid Dendritic Cell Neoplasm (BPDCN): Clinical Features and Histopathology with a Therapeutic Overview
Gerardo Cazzato, Marialessandra Capuzzolo, Emilio Bellitti, et al.
Hematology Reports (2023) Vol. 15, Iss. 4, pp. 696-706
Open Access | Times Cited: 3
Gerardo Cazzato, Marialessandra Capuzzolo, Emilio Bellitti, et al.
Hematology Reports (2023) Vol. 15, Iss. 4, pp. 696-706
Open Access | Times Cited: 3
18F-FDG PET/CT findings in a patient with blastic plasmacytoid dendritic cell neoplasm and post-transplant lymphoproliferative disorder after hematopoietic stem cell transplantation: a case report
Jinzhi Chen, Xi Zhang, Linlin Ma, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 2
Jinzhi Chen, Xi Zhang, Linlin Ma, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 2
Blastic Plasmacytoid Dendritic Cell Neoplasm With Central Nervous System Involvement: A Case Report
Diego M. Castro, Oliver Perilla Suárez, Jorge Sierra, et al.
Cureus (2022)
Open Access | Times Cited: 4
Diego M. Castro, Oliver Perilla Suárez, Jorge Sierra, et al.
Cureus (2022)
Open Access | Times Cited: 4
Allogeneic hematopoietic stem cell transplantation with myeloablative conditioning regimen for blastic plasmacytoid dendritic cell neoplasm patients in complete remission: a single center study
Yue Lü, Ruijuan Sun, Jianping Zhang, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2022) Vol. 63, Iss. 13, pp. 3092-3099
Closed Access | Times Cited: 4
Yue Lü, Ruijuan Sun, Jianping Zhang, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2022) Vol. 63, Iss. 13, pp. 3092-3099
Closed Access | Times Cited: 4
Low-dose venetoclax combined with azacitidine for blastic plasmacytoid dendritic cell neoplasm: a case report and literature review
Qiuyan Wang, Yajing Zhao, Xiao Zang, et al.
Annals of Hematology (2024) Vol. 103, Iss. 3, pp. 999-1005
Closed Access
Qiuyan Wang, Yajing Zhao, Xiao Zang, et al.
Annals of Hematology (2024) Vol. 103, Iss. 3, pp. 999-1005
Closed Access
Tumeur à cellules dendritiques plasmocytoïdes blastiques
G. Jeudy, S. Dalac‐Rat, B. Bonniaud, et al.
Annales de Dermatologie et de Vénéréologie - FMC (2024) Vol. 4, Iss. 4, pp. 270-273
Closed Access
G. Jeudy, S. Dalac‐Rat, B. Bonniaud, et al.
Annales de Dermatologie et de Vénéréologie - FMC (2024) Vol. 4, Iss. 4, pp. 270-273
Closed Access
Blastic Plasmacytoid Dendritic Cell Neoplasm Presenting as Solitary Violaceous Thigh Plaque: Answer
Yazan Alhalaseh, Karthik Krishnamurthy, Dinesh Pradhan
American Journal of Dermatopathology (2024) Vol. 46, Iss. 12, pp. 878-879
Closed Access
Yazan Alhalaseh, Karthik Krishnamurthy, Dinesh Pradhan
American Journal of Dermatopathology (2024) Vol. 46, Iss. 12, pp. 878-879
Closed Access
Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Mostafa Abdallah, Kristen McCullough, Rimal Ilyas, et al.
Blood Cancer Journal (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Mostafa Abdallah, Kristen McCullough, Rimal Ilyas, et al.
Blood Cancer Journal (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Blastic Plasmacytoid Dendritic Cell Neoplasm: A Case Report
Abdulrahman Nasiri, Arwa Lami, Alanoud Alhumaidi, et al.
Cureus (2023)
Open Access | Times Cited: 1
Abdulrahman Nasiri, Arwa Lami, Alanoud Alhumaidi, et al.
Cureus (2023)
Open Access | Times Cited: 1
Venetoclax Combined with Azacytidine Can Be a First-line Treatment Option for Elderly Blastic Plasmacytoid Dendritic Cell Neoplasm
Yasuhiro Nagate, Aya Nakaya, Ren Kamimura, et al.
Internal Medicine (2023) Vol. 62, Iss. 17, pp. 2547-2551
Open Access | Times Cited: 1
Yasuhiro Nagate, Aya Nakaya, Ren Kamimura, et al.
Internal Medicine (2023) Vol. 62, Iss. 17, pp. 2547-2551
Open Access | Times Cited: 1
Clinical features, immune profile and induction chemotherapy options for blastic plasmacytoid dendritic cell neoplasm: a systematic review and meta-analysis
Honggang Guo, Mingyue Shi
Future Oncology (2023) Vol. 19, Iss. 7, pp. 531-543
Closed Access
Honggang Guo, Mingyue Shi
Future Oncology (2023) Vol. 19, Iss. 7, pp. 531-543
Closed Access
